The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
…
continue reading
1
Additional Advances in Multiple Myeloma Research and Clinical Trials With Rahul Banerjee, MD, FACP
5:54
5:54
Play later
Play later
Lists
Like
Liked
5:54
Dr. Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, Fred Hutchinson Cancer Center, is currently serving as chair of i3 Health’s online activity and fellows meeting series, Leveraging BCMA-Directed Therapies for Improved Patient Outcomes in Relapsed/Refractory Multiple Myeloma. Since recording…
…
continue reading
1
Recurrent/Metastatic HNSCC: Answers To Frequently Asked Questions With Assuntina G. Sacco, MD
5:14
5:14
Play later
Play later
Lists
Like
Liked
5:14
In this video, Dr. Assuntina G. Sacco, Associate Professor of Internal Medicine, Co-Director of the Hanna and Mark Gleiberman Head and Neck Cancer Center, and Disease Team Leader–Head and Neck at UC San Diego Moores Cancer Center, answers questions asked by the audience during her CME/NCPD–approved activity with i3 Health, Recurrent/Metastatic Head…
…
continue reading
1
Acid Sphingomyelinase Deficiency: Answers To Frequently Asked Questions With Neal Weinreb, MD
11:15
11:15
Play later
Play later
Lists
Like
Liked
11:15
In this video, Dr. Neal Weinreb, Voluntary Associate Professor for Human Genetics at the University of Miami Miller School of Medicine, answers questions asked by the audience during his CME/NCPD–approved activity with i3 Health, Exploring Treatment Advances for Acid Sphingomyelinase Deficiency (ASMD) in Adults. Dr. Weinreb shares insights into scr…
…
continue reading
1
Every Cure: Unlocking Drug Potential With Artificial Intelligence - Waqas Haque and Tracey Sikora
12:20
12:20
Play later
Play later
Lists
Like
Liked
12:20
In this installment of Oncology Data Advisor's Exploring Artificial Intelligence in Oncology series, Dr. Waqas Haque, Fellows Forum member and incoming Hematology/Oncology Fellow at the University of Chicago, speaks with Tracey Sikora, Co-Founder of Every Cure, a nonprofit organization whose mission is to repurpose existing FDA-approved drugs for o…
…
continue reading
1
Acute Myeloid Leukemia (AML) Awareness Day: Evolving Treatment Directions
45:45
45:45
Play later
Play later
Lists
Like
Liked
45:45
In honor of Acute Myeloid Leukemia (AML) Awareness Day, Oncology Data Advisor Editorial Board and Fellows Forum members Tristan Knight, MD, FRCPC, Richa Thakur, MD, and Joseph Kalis, PharmD, BCOP, hosted a live panel discussion covering the evolving treatment landscape for AML, including: • Novel therapies and combinations such as chimeric antigen …
…
continue reading
1
Testicular Cancer Awareness Month: Improving Detection, Management, and Survivorship
10:09
10:09
Play later
Play later
Lists
Like
Liked
10:09
In honor of Testicular Cancer Awareness Month, Oncology Data Advisor Fellows Forum members Samuel Kareff, MD, MPH, Waqas Haque, MD, MPH, and Matthew Hadfield, DO, sat down to discuss improving early detection, minimizing toxicities of treatment, and optimizing long-term survivorship, particularly for adolescent and young adult (AYA) survivors of te…
…
continue reading
1
Celebrating Head and Neck Cancer Awareness Month
17:40
17:40
Play later
Play later
Lists
Like
Liked
17:40
In celebration of Head and Neck Cancer Awareness Month this April, Oncology Data Advisor Fellows Forum and Editorial Board Members Samuel Kareff, MD, MPH; Matthew Hadfield, DO; and Nagashree Seetharamu, MD, sat down to discuss the epidemiology of head and neck squamous cell carcinomas (HNSCC), the diagnostic and treatment process of HNSCC, includin…
…
continue reading
1
Esophageal Cancer Awareness Month: Treatment Advances and Tools for Maximizing Tolerability
18:29
18:29
Play later
Play later
Lists
Like
Liked
18:29
This April, Oncology Data Advisor is raising awareness for Esophageal Cancer Awareness Month. In this interview, Oncology Data Advisor Editorial Board and Fellows Forum members Dr. Joseph Kalis, Dr. Matthew Hadfield, and Dr. Samuel Kareff discuss rising trends, treatment advances, and emerging management strategies for esophageal cancer, including …
…
continue reading
1
Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Updates on LINKER-MM1 From AACR 2024
17:11
17:11
Play later
Play later
Lists
Like
Liked
17:11
In this interview from the American Association for Cancer Research (AACR) 2024 Annual Meeting, Dr. Alankrita Taneja, third-year Hematology/Oncology Fellow at Roswell Park Cancer Institute and Oncology Data Fellows Forum Member, speaks with Dr. Sundar Jagannath, Professor of Medicine (Hematology and Medical Oncology) and Director of the Center of E…
…
continue reading
1
Improving Breast Cancer Surgical Outcomes With Lymphovenous Bypass
31:14
31:14
Play later
Play later
Lists
Like
Liked
31:14
In this interview, Jason Mouabbi, MD, an Oncology Data Advisor Editorial Board Member and Assistant Professor in the Department of Breast Oncology at the University of Texas MD Anderson Cancer Center, sat down with Valerie Brutus, MD, FACS, a Breast Surgical Oncologist at St. Vincent's Medical Center of Hartford HealthCare, and Elizabeth Stirling C…
…
continue reading
Adolescent and Young Adult (AYA) Cancer Awareness Week, April 1 to 5, 2024, is a time to shine a spotlight on adolescent and young adult cancer patients and survivors. To commemorate the week, Lauren Ghazal, Megan-Claire Chase, and Allison Rosen, all members of the Oncology Data Advisor Editorial Board, sat down for a conversation to highlight the …
…
continue reading
1
Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research: Christopher Lieu, MD
8:11
8:11
Play later
Play later
Lists
Like
Liked
8:11
Dr. Christopher Lieu, Associate Director of Clinical Research at the University of Colorado Cancer Center and Vice Chair of the National Comprehensive Cancer Network (NCCN), is currently serving as chair of i3 Health's online activity, live webinar, and meeting series, Hitting the Target in HER2-Positive Metastatic Colorectal Cancer. With numerous …
…
continue reading
1
National Doctor’s Day With Samuel Kareff, MD, MPH, and Matthew Hadfield, DO
14:49
14:49
Play later
Play later
Lists
Like
Liked
14:49
In this edition of the Oncology Data Fellows Forum in celebration of National Doctor's Day, Samuel Kareff, MD, MPH, and Matthew Hadfield, DO, discuss the highs and lows of working in this field and why it is important to take a moment to celebrate being a physician, your fellow physicians, and your patients.…
…
continue reading
1
Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes
11:36
11:36
Play later
Play later
Lists
Like
Liked
11:36
In this edition of Oncology Data Advisor celebrating Kidney Cancer Awareness Month Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan discuss the rising incidence of kidney cancer, warning signs and symptoms to look out for, environmental risk factors such as tobacco use, emerging treatment strategies using immunotherapy and adjuvant the…
…
continue reading
1
Fighting Hereditary Colorectal Cancer With Genetic Counseling: Catherine Skefos and Julie Moskowitz
24:12
24:12
Play later
Play later
Lists
Like
Liked
24:12
In this edition of "Bridging the Gap in Cancer Care Through Genetic Counseling," Editorial Member Catherine Skefos speaks with her colleague Julie Moskowitz, MS, Genetic Counselor in the Gastrointestinal (GI) Center at MD Anderson Cancer Center, about hereditary aspects of colorectal cancer, how she counsels patients and families regarding their ri…
…
continue reading
1
International Women’s Day: Perspectives in Medicine, Nursing, and Fellowship
36:19
36:19
Play later
Play later
Lists
Like
Liked
36:19
In this panel discussion in honor of International Women's Day on March 8, Dr. Richa Thakur, Dr. Nida Khan, Dr. Lauren Ghazal, and Dr. Gurbakhash Kaur discuss their perspectives as women in the fields of medicine and nursing, including their advice for negotiating, seeking mentors, overcoming imposter syndrome, building confidence, and making your …
…
continue reading
1
Additional Advances in aTTP Research and Clinical Trials With Spero Cataland, MD
8:47
8:47
Play later
Play later
Lists
Like
Liked
8:47
Dr. Spero Cataland, Professor of Internal Medicine and the Benign Hematology Section Head at The Ohio State University, Wexner Medical Center, is currently serving as chair of i3 Health's free CME/NCPD activity and Hematology Fellows Lecture Series, Current Standards and New Directions in Treatment of Acquired Thrombotic Thrombocytopenic Purpura (a…
…
continue reading
1
Kidney Cancer Awareness Month: Spotlight on Genetic Counseling
21:23
21:23
Play later
Play later
Lists
Like
Liked
21:23
In this interview for Kidney Cancer Awareness Month, Hiam Abdel-Salam, MS, CGC, speaks with Donika Saporito, MS, a Certified Genetic Counselor in the Genitourinary Center at MD Anderson Cancer Center, who provides an overview of genetic testing for hereditary kidney cancer syndromes and how she personally counsels the patients she sees.…
…
continue reading
51
Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD
10:39
10:39
Play later
Play later
Lists
Like
Liked
10:39
Last year, Brian Rubin, MD, PhD, Chair of Pathology and Laboratory Medicine and the Chief of Diagnostics at the Cleveland Clinic, served as co-chair for i3 Health's continuing medical education (CME)–/nursing continuing professional development (NCPD)–approved virtual tumor board: Multidisciplinary Management of Advanced Soft Tissue Sarcoma, alongs…
…
continue reading
51
Multiple Myeloma Awareness Month 2024: What Patients Need to Know
58:07
58:07
Play later
Play later
Lists
Like
Liked
58:07
For Multiple Myeloma Awareness Month this March, Oncology Data Advisor hosted a live panel discussion geared towards patients living with multiple myeloma. Dr. Rahul Banerjee, Dr. Alankrita Taneja, Dr. Richa Thakur, and Dr. Gurbakhash Kaur helped put the myriad of new developments in multiple myeloma treatment into perspective for patients and answ…
…
continue reading
51
Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD
7:18
7:18
Play later
Play later
Lists
Like
Liked
7:18
Last year, Jaffer Ajani, MD, Professor in the Department of Gastrointestinal (GI) Medical Oncology at MD Anderson Cancer Center, served as co-chair of i3 Health's Virtual Tumor Board, Building Comprehensive Care Plans in Esophagogastric Cancers, along with Lei Zhao, MD, PhD, Assistant Professor of Pathology at Brigham and Women's Hospital, and Kell…
…
continue reading
101
Introduction to Genetic Counseling With Hiam Abdel-Salam, MS, CGC, and Catherine Skefos, MA, MS, CGC
38:35
38:35
Play later
Play later
Lists
Like
Liked
38:35
In this first episode of Oncology Data Advisor’s new podcast series, “Bridging the Gap in Cancer Care Through Genetic Counseling,” Hiam Abdel-Salam and Catherine Skefos provide an introduction to genetic counseling, including how they entered the field, what they do on a day-to-day basis, scenarios in which patients should or should not consider me…
…
continue reading
101
Thirty Years in the Making: The Approval of Lifileucel for Metastatic Melanoma
9:42
9:42
Play later
Play later
Lists
Like
Liked
9:42
Following the recent approval of lifileucel for unresectable or metastatic melanoma—the first cellular therapy to receive an approval for solid tumors—Matthew Hadfield, DO, member of the Oncology Data Advisor Fellows Forum and third-year Fellow at Brown University, sat down with Richard Carvajal, MD, Oncology Data Advisor Editorial Board Member and…
…
continue reading
101
International Women’s Day With Alankrita Taneja, Maria Badillo, Ulka Vaishampayan, and Morana Vojnic
25:03
25:03
Play later
Play later
Lists
Like
Liked
25:03
In celebration of Women's Day on March 8, Oncology Data Advisor hosted a live panel discussion in which the women of our Editorial Board and Fellows Forum share what the day means to them, progress that has been made in female representation in leadership roles, continued obstacles to overcome, and the value of encouraging and mentoring other women…
…
continue reading
101
Discovering Research Advances in Mesothelioma: Samuel Kareff, MD, MPH, and Estela Rodriguez, MD, MPH
9:43
9:43
Play later
Play later
Lists
Like
Liked
9:43
In this Fellows Forum interview, Dr. Samuel Kareff speaks with Dr. Estela Rodriguez, Clinical Research Lead of the Thoracic Site Disease Group at the University of Miami Sylvester Comprehensive Cancer Center, about recent research advances in mesothelioma, the emerging roles of immunotherapy and biomarker testing, and the importance of ensuring acc…
…
continue reading
101
Rare Disease Day 2024 With Rahul Banerjee, Matthew Hadfield, Joseph Kalis, and Nagashree Seetharamu
43:43
43:43
Play later
Play later
Lists
Like
Liked
43:43
On Rare Disease Day on February 29, members of the Oncology Data Advisor Editorial Board and Fellows Forum hosted a live panel discussion focused on the rare diseases that they treat, including tireless efforts underway to develop novel treatment strategies, enhance quality of life, and improve outcomes for patients.…
…
continue reading
101
Exploring the Intersection of Emergency Medicine and Oncology With Joseph Oropeza and Joseph Kalis
20:25
20:25
Play later
Play later
Lists
Like
Liked
20:25
In this interview, Joseph Kalis, PharmD, BCOP, introduces Joseph Oropeza, PharmD, BCCP, one of the newest Editorial Board members of Oncology Data Advisor. Dr. Oropeza shares what he does as an Emergency Medicine Pharmacist, the intersections of oncology and the emergency department, the steps he takes to manages oncologic emergencies, and the impo…
…
continue reading
1
Colorectal Cancer Awareness Month With Allison Rosen, MS, and Matthew Hadfield, DO
12:13
12:13
Play later
Play later
Lists
Like
Liked
12:13
In honor of Colorectal Cancer Awareness Month this March, Allison Rosen, MS, and Matthew Hadfield, DO, members of the OncData Editorial Board and Fellows Forum, sat down to discuss their perspectives on the month from both the clinical and survivorship viewpoints, including efforts to advocate for increased clinical trial funding, recent updates in…
…
continue reading
1
Expanding Clinical Trial Access With Decentralization and Technology: Waqas Haque and Shaalan Beg
20:05
20:05
Play later
Play later
Lists
Like
Liked
20:05
In this installment of Oncology Data Advisor's Exploring AI in Oncology series, Dr. Waqas Haque speaks with Dr. Shaalan Beg, an Adjunct Associate Professor at the University of Texas (UT) Southwestern, who is spearheading efforts to decentralize clinical trials in oncology and expand access for eligible patients. Dr. Beg describes the tools that ar…
…
continue reading
1
National Donor Day: How To Be the Match With Richa Thakur, MD, and Will Smith
9:57
9:57
Play later
Play later
Lists
Like
Liked
9:57
On February 14, Oncology Data Advisor is celebrating National Donor Day and recognizing the contributions of individuals who have given organ and tissue donations for patients in need. In this interview, Fellows Forum member Dr. Richa Thakur has a conversation with Will Smith, a High School History Teacher, who gave an anonymous stem cell donation …
…
continue reading
1
Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forward
30:03
30:03
Play later
Play later
Lists
Like
Liked
30:03
In this interview, Dr. Jason Mouabbi, OncData Editorial Board Member and Breast Medical Oncologist at MD Anderson Cancer Center, speaks with Dr. Ross Maclean and Michael Glover about the debate surrounding accelerated FDA approvals, including their benefits, risks, and ways that physicians, patients, pharmaceutical companies, and the FDA can collab…
…
continue reading
1
National Cancer Prevention Month: Rising Trends and How to Combat Them
16:01
16:01
Play later
Play later
Lists
Like
Liked
16:01
In honor of National Cancer Prevention Month 2024, members of the Oncology Data Advisor Editorial Board and Fellows Forum sat down for a panel discussion about the rising incidence of cancer diagnoses, factors contributing to them, and how to counsel patients in light of these emerging trends.By i3 Health
…
continue reading
1
Breaking Developments in Neuroendocrine Tumor Research: Dr. Samuel Kareff and Dr. Aman Chauhan
14:43
14:43
Play later
Play later
Lists
Like
Liked
14:43
In this Fellows Forum interview, Samuel Kareff, MD, MPH, interviews Aman Chauhan, MD, Leader of the Neuroendocrine Tumor Program at the University of Miami, Sylvester Comprehensive Cancer Center, about how he became involved in neuroendocrine cancer research, the latest developments in novel therapies, and the future of using radiopharmaceuticals a…
…
continue reading
1
World Cancer Day 2024 with Oncology Data Advisor
24:06
24:06
Play later
Play later
Lists
Like
Liked
24:06
In honor of World Cancer Day on February 4, members of the Oncology Data Advisor Fellows Forum and Editorial Board joined forces for a thought-provoking discussion about improving cancer care on a global scale, including treatment access, molecular testing, clinical trial diversity, and patient advocacy worldwide.…
…
continue reading
1
Gallbladder and Bile Duct Cancer Awareness Month: Improving Screening and Treatment Options
10:53
10:53
Play later
Play later
Lists
Like
Liked
10:53
In honor of Gallbladder and Bile Duct Cancer Awareness Month this February, Fellows Forum members Dr. Waqas Haque and Dr. Matthew Hadfield sat down for a discussion on the challenges in diagnosis of gallbladder and bile duct cancers and the importance of genetic sequencing for making targeted treatments available for patients.…
…
continue reading
1
National Cancer Prevention Month With Stephen Freedland and William Aronson
21:20
21:20
Play later
Play later
Lists
Like
Liked
21:20
In honor of National Cancer Prevention Month, Dr. Stephen Freedland, Urologist at Cedars-Sinai Medical Center and Oncology Data Advisor Editorial Board Member, sat down with Dr. William Aronson, Professor of Urology at the University of California, Los Angeles (UCLA) and Chief of Urologic Oncology at the West Los Angeles Veterans Affairs (VA) Medic…
…
continue reading
1
Highlights of Multiple Myeloma Research Presented at ASH With Urvi Shah, MD
16:13
16:13
Play later
Play later
Lists
Like
Liked
16:13
At the recent American Society of Hematology (ASH) Annual Meeting, numerous updates were presented with the potential to impact practice in relapsed/refractory multiple myeloma. While at the meeting, Urvi Shah, MD, Assistant Attending in the Myeloma Service at Memorial Sloan Kettering Cancer Center, shares some of most significant highlights of the…
…
continue reading
1
Streamlining the Pathology Workflow Through AI: Waqas Haque and Leif Honda of TriMetis
21:04
21:04
Play later
Play later
Lists
Like
Liked
21:04
This second episode of Oncology Data Advisor's podcast series, Exploring Artificial Intelligence in Oncology, features Leif Honda, Chief Innovation Officer at TriMetis, a digital pathology company focused on improving patient outcomes by accelerating human tissue-based research, development, and testing. Dr. Waqas Haque, member of the Oncology Data…
…
continue reading
1
Capivasertib for PIK3CA/AKT1/PTEN–Altered Breast Cancer With Jason Mouabbi, MD, and Carlos Doti, MD
14:13
14:13
Play later
Play later
Lists
Like
Liked
14:13
Recently, the FDA granted approval to capivasertib in combination with fulvestrant for patients with hormone receptor–positive, human epidermal growth factor receptor 2 (HER2)–negative locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN alterations. In this interview, Editorial Board member Dr. Jason Mouabbi speaks with D…
…
continue reading
1
Patterns of Care With BTK Inhibitors for CLL/SLL in the Community Setting: David Andorsky, MD
6:34
6:34
Play later
Play later
Lists
Like
Liked
6:34
At the recent American Society of Hematology (ASH) Annual Meeting in San Diego, Dr. David Andorsky, MD, a Clinical Hematologist and Medical Oncologist at the Rocky Mountain Cancer Centers in Boulder, Colorado, presented his research and observations regarding patterns of care with Bruton tyrosine kinase (BTK) inhibitors and the distribution of soci…
…
continue reading
1
Investigating Hypomethylating Agents for Myelodysplastic Syndromes With Amer Zeidan
8:42
8:42
Play later
Play later
Lists
Like
Liked
8:42
Recently, at the American Society of Hematology (ASH) Annual Meeting, Amer Zeidan, MBBS, MHS, the Interim Chief of Hematologic Malignancies Division at the Yale Cancer Center, presented his abstract regarding an investigation of oral decitabine and cedazuridine versus intravenous/subcutaneous hypomethylating agents (HMA) for patients with myelodysp…
…
continue reading
1
Epcoritamab for FL: Matt Hadfield, Alankrita Taneja, Tahi Ahmadi, Jacqueline Nielsen
28:21
28:21
Play later
Play later
Lists
Like
Liked
28:21
Recently, Genmab and AbbVie announced updated results of the phase 1/2 EPCORE™ NHL-1 clinical trial of epcoritamab (epco) for patients with relapsed/refractory follicular lymphoma. In this interview, Dr. Matthew Hadfield and Dr. Alankrita Taneja of the Oncology Data Advisor Fellows Forum speak with Dr. Tahi Ahmadi, Chief Medical Officer at Genmab, …
…
continue reading
1
Managing Acute Leukemias and Lymphomas When Patients Stay Local: Dipti Patel-Donnelly, MD
4:50
4:50
Play later
Play later
Lists
Like
Liked
4:50
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Real-World Outcomes of Brexuctabtagene Autoleucel for B-Cell ALL: Evandro Bezerra, MD
5:38
5:38
Play later
Play later
Lists
Like
Liked
5:38
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Nurse Navigation to Address Socioeconomic Disparities in ALL Treatment: Greg Knight, MD
9:57
9:57
Play later
Play later
Lists
Like
Liked
9:57
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Exploring Revumenib for KMT2-Rearranged Acute Leukemias in the AUGMENT Trial: Ibrahim Aldoss, MD
8:05
8:05
Play later
Play later
Lists
Like
Liked
8:05
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Utilizing ctDNA to Assess Survival With Odronextamab for FL and DLBCL: Jon Arnason, MD
4:52
4:52
Play later
Play later
Lists
Like
Liked
4:52
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Investigating Talquetamab + Pomalidomide in the MonumenTAL-2 Study: Jeffrey Matous, MD
5:13
5:13
Play later
Play later
Lists
Like
Liked
5:13
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Improving QOL in Multiple Myeloma With Bortezomib Dose Reduction: Rahul Banerjee and Gurbakhash Kaur
8:16
8:16
Play later
Play later
Lists
Like
Liked
8:16
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading
1
Guiding Dietary Choices During Multiple Myeloma Treatment: Richa Parikh, MD
5:47
5:47
Play later
Play later
Lists
Like
Liked
5:47
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconom…
…
continue reading